Traveler's Diarrhea - Epidemiology Insights to 2025

Publisher Name :
Date: 28-Jul-2017
No. of pages: 40
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Traveler's Diarrhea -Epidemiology Forecast, 2025" provides an overview of the epidemiology trends of Traveler's Diarrhea in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Traveler's Diarrhea. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical needs associated with the Traveler's Diarrhea. The report contains the targeted patient populations and the forecast methodology.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by DelveInsight team of industry experts.

Key Coverage and Benefits

  • The Report includes the prevalent population and how will it change over the next eight years.

  • Coverage of key Traveler's Diarrhea sub-populations and its prevalent or incident cases

  • Prevalent or incident cases segmented by age and sex.

  • The key differences in epidemiology patterns across the seven market segments.

Reasons to buy

  • Developing business strategies by understanding the trends shaping and driving the global Traveler's Diarrhea market.

  • Identifying prevalent patient populations as well as risk factors in the global Traveler's Diarrhea market will help to improve product design, pricing, and launch plans.

  • Organize sales and marketing efforts by identifying the best opportunities for Traveler's Diarrhea therapeutics in each of the markets covered.

Traveler's Diarrhea - Epidemiology Insights to 2025

Table of Contents

1. Report Introduction

2. Snapshot of Total Prevalent or Incident cases by 7 MM

3. Executive Summary
Key Findings

4. Traveler's Diarrhea Overview
Traveler's Diarrhea Definition
Pathophysiology
Symptoms
Etiology

5. Risk Factors Associated with Traveler's Diarrhea

6. Disease Burden & Unmet Need in the Market

7. Epidemiology and Patient Populations
Key Findings
Key Sources used and Forecast Methodology
Prevalent Cases and Incident Cases-2015-2025
Prevalent & Incident Cases by Category-2015-2025
Age-Specific Prevalent/ Incident Cases of Traveler's Diarrhea
Sex-Specific Prevalent/Incident Cases of Traveler's Diarrhea
Disease Type Specific Prevalent/Incident Cases of Traveler's Diarrhea

8.Prevalent & Incident Cases by 7 MM-2015-2025
Traveler's Diarrhea Epidemiology of United States-2025
Traveler's Diarrhea Epidemiology of United Kingdom-2025
Traveler's Diarrhea Epidemiology of Germany-2025
Traveler's Diarrhea Epidemiology of France-2025
Traveler's Diarrhea Epidemiology of Spain-2025
Traveler's Diarrhea Epidemiology of Italy-2025
Traveler's Diarrhea Epidemiology of Japan-2025

9. Key Takeaways

10. Appendix

11.Report Methodology

12. Consulting Services

13. Disclaimer

14. About Us

List of Tables

Table 1: Clinical subtypes of Indication
Table 2: Risk Factors
Table 3: Prevalence cases (%) Region wise
Table 4: Sources used for forecasting the data
Table 5: Traveler's Diarrhea Global Epidemiology, (2015-2025)
Table 6: Prevalent Cases of Traveler's Diarrhea (Ages =XX Years), US (2015-2025)
Table 7: Prevalent Cases of Traveler's Diarrhea By Sex (Males & Females), US (2015-2025)
Table 8: Prevalent Cases By Traveler's Diarrhea Sub-population, US (2015-2025)
Table 9: Prevalent Cases of Traveler's Diarrhea (Ages =XX Years), United Kingdom (2015-2025)
Table 10: Prevalent Cases of Traveler's Diarrhea By Sex (Males & Females), United Kingdom (2015-2025)
Table 11: Prevalent Cases By Traveler's Diarrhea Sub-population, United Kingdom (2015-2025)
Table 12: Prevalent Cases of Traveler's Diarrhea (Ages =XX Years), Germany (2015-2025)
Table 13: Prevalent Cases of Traveler's Diarrhea By Sex (Males & Females), Germany (2015-2025)
Table 14: Prevalent Cases By Traveler's Diarrhea Sub-population, Germany (2015-2025)
Table 15: Prevalent Cases of Traveler's Diarrhea (Ages =XX Years), France (2015-2025)
Table 16: Prevalent Cases of Traveler's Diarrhea By Sex (Males & Females), France (2015-2025)
Table 17: Prevalent Cases By Traveler's Diarrhea Sub-population, France (2015-2025)
Table 18: Prevalent Cases of Traveler's Diarrhea (Ages =XX Years), Italy (2015-2025)
Table 19: Prevalent Cases of Traveler's Diarrhea By Sex (Males & Females), Italy (2015-2025)
Table 20: Prevalent Cases By Traveler's Diarrhea Sub-population, Italy (2015-2025)
Table 21: Prevalent Cases of Traveler's Diarrhea (Ages =XX Years), Spain (2015-2025)
Table 22: Prevalent Cases of Traveler's Diarrhea By Sex (Males & Females), Spain (2015-2025)
Table 23: Prevalent Cases By Traveler's Diarrhea Sub-population, Spain (2015-2025)
Table 24: Prevalent Cases of Traveler's Diarrhea (Ages =XX Years), Japan (2015-2025)
Table 25: Prevalent Cases of Traveler's Diarrhea By Sex (Males & Females), Japan (2015-2025)
Table 26: Prevalent Cases By Traveler's Diarrhea Sub-population, Japan (2015-2025)

List of Figures

Figure 1: Prevalence cases (%) Region wise
Figure 2: Sources used for forecasting the data
Figure 3: Traveler's Diarrhea Global Epidemiology, (2015-2025)
Figure 4: Prevalent Cases of Traveler's Diarrhea (Ages =XX Years), US (2015-2025)
Figure 5: Prevalent Cases of Traveler's Diarrhea By Sex (Males & Females), US (2015-2025)
Figure 6: Prevalent Cases By Traveler's Diarrhea Sub-population,US (2015-2025)
Figure 7: Prevalent Cases of Traveler's Diarrhea (Ages =XX Years), United Kingdom (2015-2025)
Figure 8: Prevalent Cases of Traveler's Diarrhea By Sex (Males & Females), United Kingdom (2015-2025)
Figure 9: Prevalent Cases By Traveler's Diarrhea Sub-population,United Kingdom (2015-2025)
Figure 10: Prevalent Cases of Traveler's Diarrhea (Ages =XX Years), Germany (2015-2025)
Figure 11: Prevalent Cases of Traveler's Diarrhea By Sex (Males & Females), Germany (2015-2025)
Figure 12: Prevalent Cases By Traveler's Diarrhea Sub-population,Germany (2015-2025)
Figure 13: Prevalent Cases of Traveler's Diarrhea (Ages =XX Years), France (2015-2025)
Figure 14: Prevalent Cases of Traveler's Diarrhea By Sex (Males & Females), France (2015-2025)
Figure 15: Prevalent Cases By Traveler's Diarrhea Sub-population,France (2015-2025)
Figure 16: Prevalent Cases of Traveler's Diarrhea (Ages =XX Years), Italy (2015-2025)
Figure 17: Prevalent Cases of Traveler's Diarrhea By Sex (Males & Females), Italy (2015-2025)
Figure 18: Prevalent Cases By Traveler's Diarrhea Sub-population,Italy (2015-2025)
Figure 19: Prevalent Cases of Traveler's Diarrhea (Ages =XX Years), Spain (2015-2025)
Figure 20: Prevalent Cases of Traveler's Diarrhea By Sex (Males & Females), Spain (2015-2025)
Figure 21: Prevalent Cases By Traveler's Diarrhea Sub-population,Spain (2015-2025)
Figure 22: Prevalent Cases of Traveler's Diarrhea (Ages =XX Years), Japan (2015-2025)
Figure 23: Prevalent Cases of Traveler's Diarrhea By Sex (Males & Females), Japan (2015-2025)
Figure 24: Prevalent Cases By Traveler's Diarrhea Sub-population,Japan (2015-2025)
  • Global Gastroparesis Drugs Market Size, Status and Forecast 2022
    Published: 06-Oct-2017        Price: US 3300 Onwards        Pages: 99
    This report studies the global Gastroparesis Drugs market, analyzes and researches the Gastroparesis Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - GlaxoSmithKline - Johnson & Johnson - Cadila Pharmaceuticals - Valeant - Evoke Pharma - Teva Pharmaceutical Industries - Theravance Biopharma Market segment by Regions/Cou......
  • Global Chronic Idiopathic Constipation Drug Market Forecast 2017-2025
    Published: 24-Sep-2017        Price: US 2500 Onwards        Pages: 122
    Key Findings Global Chronic Idiopathic Constipation drug market is estimated to grow at a CAGR of 8.37% during the forecast period of 2017-2025. The important drivers propelling the market growth are the modern dietary habits, rising elderly population and the improved and efficient drugs in the pipeline. Linaclotide is the major type of drug popular in this market. Market Insight The CIC drug market is segmented based on drug types and also on the basis of prescript......
  • Global Opioid Induced Constipation Drug Market Forecast 2017-2025
    Published: 24-Sep-2017        Price: US 2500 Onwards        Pages: 125
    Key Findings Global Opioid-Induced Constipation (OIC) drug market is estimated to grow at a CAGR of 7.08% during the forecast period of 2017 - 2025. The major drivers responsible for the market growth include the growing use of opioid, rising geriatric population, growing opioid prescription in North America and Europe, detection of safety threats and the easy availability of improved and effective OIC drugs. Some of the commonly prescribed opioids are Percocet, Vicodin, and codeine.......
  • Asia-Pacific Chronic Idiopathic Constipation Drug Market Forecast 2017-2025
    Published: 24-Sep-2017        Price: US 1250 Onwards        Pages: 67
    Key Findings The Asia-Pacific chronic idiopathic constipation drug market is predicted to expand at a CAGR of 10.30% over the forecast period of 2017-2025. The revenue generated by the market is expected to rise from $683 million in 2016 and reach $1615 million by 2025. MARKET INSIGHTS The Asian CIC drug market can be segmented by the type of drug and by the type of prescription. The drug lubiprostone is dominating the drug segment closely followed by the drug linaclotide. B......
  • Europe Chronic Idiopathic Constipation Drug Market Forecast 2017-2025
    Published: 24-Sep-2017        Price: US 1250 Onwards        Pages: 65
    Key Findings The Europe chronic idiopathic constipation drug market is estimated to grow at a CAGR of 8.80% during the forecast years of 2017-2025.The market value is estimated to increase from $1283 million in 2016 and reach $2721 million by 2025. Market Insights The market has plenty of growth opportunities owing to the unmet needs of CIC drugs in certain countries. The market can be segmented into two types on the basis of the type of prescriptions and the type of drugs. ......
  • North America Chronic Idiopathic Constipation Drug Market Forecast 2017-2025
    Published: 24-Sep-2017        Price: US 1250 Onwards        Pages: 68
    Key Findings The North America Chronic Idiopathic Constipation Drug Market is expected to grow at a CAGR of 6.92%. The market value is expected to rise from $1822 million in 2016 to $3358 million by 2025. The changing modern dietary habits, chances of cancer or other systematic disease leading to CIC and the growing increasing elderly population are some of the factors driving the market. Market Insights The North America chronic idiopathic constipation drug market i......
  • Asia Pacific Opioid Induced Constipation (OIC) Drug Market Forecast 2017-2025
    Published: 24-Sep-2017        Price: US 1250 Onwards        Pages: 65
    Key Findings The Asia-Pacific Opioid Constipation Drug market is estimated to grow at a CAGR of 8.99% during the forecast period of 2017-2025. The market worth is expected to increase from $797 million in 2016 and reach $1708 million by 2025. The ease of the availability of new and improved drugs and the growing geriatric population are currently driving the Asian Market. Market Insights The Asian market can be classified on the basis of drug type and prescription type. The ......
  • Europe Opioid Induced Constipation (OIC) Drug Market Forecast 2017-2025
    Published: 24-Sep-2017        Price: US 1250 Onwards        Pages: 62
    Key Findings The Europe opioid-induced constipation drug market is expected to grow at a CAGR of 7.51% during the forecast period of 2017-2025. The market value is predicted to increase from $1497million in 2016 and reach up to $2877 million by the end of 2025. Market Insights The Europe opioid constipation drug market is mainly driven by the increasing opioids prescription in the region. The market can be segmented into two criteria. First is the market by drug type that in......
  • North America Opioid Induced Constipation (OIC) Drug Market Forecast 2017-2025
    Published: 24-Sep-2017        Price: US 1250 Onwards        Pages: 65
    Key Findings The North America opioid-induced constipation drug market is expected to command the global OIC drug market during the forecast period of 2017-2025 with an expected CAGR growth of 5.65%. The revenue generated by the market is expected to increase from $2125 million in 2016 and reach $3551 million by 2025. Market Insights The North American OIC drug market is segmented on the basis of the type of prescription and the type of drug. The prescription type market is ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs